Login / Signup

Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease.

Amy Patel JainNorman GelladaShoaib UgradarAda KumarGeorge KahalyRaymond Douglas
Published in: The British journal of ophthalmology (2020)
Orbital imaging demonstrated decreased EOM volumes and orbital fat tissue volumes after teprotumumab treatment.
Keyphrases
  • adipose tissue
  • high resolution
  • fatty acid
  • skeletal muscle
  • fluorescence imaging
  • replacement therapy